Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
Agreement is based on a risk-sharing arrangement followed by milestone and royalty payments to Evotec based on success of overall programmes
08-Nov-2023 -
Evotec SE and Dewpoint Therapeutics announced a strategic R&D collaboration to advance Dewpoint’s leading oncology pipeline programmes of condensate modifying therapeutics (“c-mods”) to Investigational New Drug Applications (“INDs”) using Evotec’s industry-leading fully integrated data-driven ...
clinical development
drug development
drug discovery
+2